,
your personalized virtual assistant to find clinical trials. Go head, 
Charles R. Dibb, MD
Three Rivers Community HospitalGrants Pass, Oregon - 97527 (541-774-5853) |
- CLINICAL TRIALS 6
- CONDITIONS10
- INTERVENTIONS16
- SINCE2006
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement
March 2009 - May 2015
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer
October 2008 - October 2010
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer
November 2007 - November 2013
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
December 2008 - April 2015
Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
October 2006 - September 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
June 2007 - July 2015
Breast Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Multiple Myeloma
Neoplasms, Plasma Cell
Neoplasms
Neoplasm Metastasis
Bone Neoplasms
Bone Marrow Diseases
Osteonecrosis
Placebo
Zoledronic Acid
Assessment Of Therapy Complications
Paclitaxel
Bevacizumab
Cisplatin
Docetaxel
Gemcitabine Hydrochloride
Cyclophosphamide
Pemetrexed Disodium
Doxorubicin Hydrochloride
Ixabepilone
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Ac Regimen
Chemotherapy
Vinorelbine Ditartrate
